Alpha-1 Antitrypsin Deficiency Patient Recruitment in Tennessee

TheraNovex connects clinical trial sponsors with pre-screened, eligible Alpha-1 Antitrypsin Deficiency patients across Tennessee, including Memphis, Nashville, Knoxville, and beyond.

Alpha-1 antitrypsin deficiency patient recruitment for augmentation therapy and gene therapy clinical trials.

Who qualifies: Adults with confirmed AATD (ZZ, SZ, or null genotype) with or without lung or liver disease.

Recruitment challenges: Genotype confirmation and AAT serum level requirements.

Our approach: Pulmonology and hepatology referral networks, Alpha-1 Foundation patient registry access.

Our recruitment network spans all major metropolitan areas in Tennessee, ensuring broad geographic coverage for your Alpha-1 Antitrypsin Deficiency trial.